ROSEN NATIONAL TRIAL COUNSEL Encourages Phathom Pharmaceuticals Inc Investors to Inquire About Securities Class Action Investigation PHAT Libyan Newswire

NEW YORK, April 11, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) resulting from allegations that Phathom may have issued materially misleading business information to the investing public.…Read More